These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11109505)

  • 1. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
    Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
    Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of oral anticoagulant treatment on D-dimers levels].
    Ombandza-Moussa E; Samama MM; Horellou MH; Chatelier AL; Elalamy I; Conard J
    Ann Biol Clin (Paris); 2001; 59(5):579-83. PubMed ID: 11602388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S; Lindmarker P
    N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study.
    Palareti G; Legnani C; Guazzaloca G; Frascaro M; Grauso F; De Rosa F; Fortunato G; Coccheri S
    Thromb Haemost; 1994 Aug; 72(2):222-6. PubMed ID: 7831656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
    Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
    Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
    Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
    Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.
    van Dongen CJ; Vink R; Hutten BA; Büller HR; Prins MH
    Arch Intern Med; 2003 Jun; 163(11):1285-93. PubMed ID: 12796064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
    Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Favaretto E; Palareti G
    Thromb Res; 2008; 122(5):610-7. PubMed ID: 18304616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
    Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapy with enoxaparin for the prevention of recurrent venous thromboembolism.
    Castro DJ; Díaz G; Martí D; Escobar C; Ortega J; García-Rull S; Picher J; Sueiro A
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):173-7. PubMed ID: 17287635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.